.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Federal Trade Commission
Fish and Richardson
Chubb
Boehringer Ingelheim
Express Scripts
Argus Health
Cantor Fitzgerald
Baxter
Novartis

Generated: July 21, 2017

DrugPatentWatch Database Preview

XANAX XR Drug Profile

« Back to Dashboard

What is the patent landscape for Xanax Xr, and when can generic versions of Xanax Xr launch?

Xanax Xr is a drug marketed by Pharmacia And Upjohn and is included in one NDA.

The generic ingredient in XANAX XR is alprazolam. There are fifteen drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the alprazolam profile page.

Summary for Tradename: XANAX XR

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list4
Bulk Api Vendors: see list34
Clinical Trials: see list22
Patent Applications: see list8,946
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:XANAX XR at DailyMed

Pharmacology for Tradename: XANAX XR

Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn
XANAX XR
alprazolam
TABLET, EXTENDED RELEASE;ORAL021434-001Jan 17, 2003ABRXYesNo► Subscribe► Subscribe
Pharmacia And Upjohn
XANAX XR
alprazolam
TABLET, EXTENDED RELEASE;ORAL021434-004Jan 17, 2003ABRXYesYes► Subscribe► Subscribe
Pharmacia And Upjohn
XANAX XR
alprazolam
TABLET, EXTENDED RELEASE;ORAL021434-002Jan 17, 2003ABRXYesNo► Subscribe► Subscribe
Pharmacia And Upjohn
XANAX XR
alprazolam
TABLET, EXTENDED RELEASE;ORAL021434-003Jan 17, 2003ABRXYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: XANAX XR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn
XANAX XR
alprazolam
TABLET, EXTENDED RELEASE;ORAL021434-001Jan 17, 20035,061,494► Subscribe
Pharmacia And Upjohn
XANAX XR
alprazolam
TABLET, EXTENDED RELEASE;ORAL021434-003Jan 17, 20035,061,494► Subscribe
Pharmacia And Upjohn
XANAX XR
alprazolam
TABLET, EXTENDED RELEASE;ORAL021434-004Jan 17, 20035,061,494► Subscribe
Pharmacia And Upjohn
XANAX XR
alprazolam
TABLET, EXTENDED RELEASE;ORAL021434-002Jan 17, 20035,061,494► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Teva
Fish and Richardson
Deloitte
Medtronic
Cipla
Julphar
Harvard Business School
McKinsey
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot